Eli Lilly growth tied to nascent diabetes drug sales Ruchika Sharma1 Nov 2022 10:15 AM ISTUS: Wall Street analysts will be focusing on sales of Eli Lilly and Co's newly approved diabetes drug Mounjaro when the company reports results on...
Lilly to acquire Akouos for Hearing Loss treatments Ruchika Sharma19 Oct 2022 3:30 PM ISTUnder the terms of the transaction, Lilly will acquire all of the outstanding shares of Akouos for $12.50 per share in cash, plus one contingent value...
Eli Lilly gets USFDA Fast Track designation for Tirzepatide to treat adults with obesity Ruchika Sharma7 Oct 2022 12:15 PM ISTTirzepatide is a once-weekly GIP (glucose-dependent insulinotropic polypeptide) receptor and GLP-1 (glucagon-like peptide-1) receptor agonist.
USFDA nod to Eli Lilly RET Inhibitor Retevmo for adults with advanced or metastatic solid tumors with a RET Gene Fusion, regardless of type Ruchika Sharma23 Sept 2022 4:20 PM ISTIn addition to the tumor-agnostic approval, the USFDA has granted traditional approval for Retevmo in adult patients with locally advanced or...
FIRST: Eli Lilly gets USFDA nod for alopecia areata pill Olumiant Ruchika Sharma14 Jun 2022 1:00 PM ISTOLUMIANT is a once-daily, oral JAK inhibitor discovered by Incyte and licensed to Lilly and is available through specialty pharmacies nationwide.
Eli Lilly sued by whistleblower over drug manufacturing problems Ruchika Sharma8 Jun 2022 3:27 PM ISTThe company also said it "continues to cooperate" with a Justice Department subpoena and to work collaboratively with the U.S. Food and Drug...
Eli Lilly Mounjaro injection gets USFDA nod for type 2 diabetes Ruchika Sharma14 May 2022 3:17 PM ISTMounjaro will be available in six doses (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg) and will come in Lilly's auto-injector pen with a pre-attached,...
USFDA nod to Eli Lilly Olumiant for certain hospitalized Covid patients Ruchika Sharma13 May 2022 1:02 PM ISTOLUMIANT is a once-daily, oral JAK inhibitor discovered by Incyte and licensed to Lilly.
Eli Lilly appoints Mary Lynne Hedley to its Board Ruchika Sharma8 May 2022 11:00 AM ISTIndianapolis: The Board of Directors of Eli Lilly and Company has elected Mary Lynne Hedley, Ph.D., as a new member, effective May 15, 2022. As a...
Setback: Eli Lilly- Innovent lung cancer drug Sintilimab rejected by USFDA Ruchika Sharma26 March 2022 12:41 PM ISTFDA and its advisers had raised concerns over the lack of population diversity in a single-country trial.
Eli Lilly, Boehringer Ingelheim gets USFDA nod for Jardiance to treat heart failure regardless of ejection fraction MD Bureau26 Feb 2022 11:00 AM ISTIndianapolis: Eli Lilly and Company and Boehringer Ingelheim have recently announced that the U.S. Food and Drug Administration (USFDA) has...
Eli Lilly launches Institute for Genetic Medicine MD Bureau26 Feb 2022 9:00 AM ISTThrough the work of the Institute, Lilly intends to fuel the development of gentic medicines, which already account for more than 20 percent of...
